1.5 ML buprenorphine 200 MG/ML Prefilled Syringe [Sublocade]

RxCUI
1996193
RxNorm name
1.5 ML buprenorphine 200 MG/ML Prefilled Syringe [Sublocade]
Display name
1.5 ML buprenorphine 200 MG/ML Prefilled Syringe [Sublocade]
Full name
1.5 ML buprenorphine 200 MG/ML Prefilled Syringe [Sublocade]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SUBLOCADEBUPRENORPHINEIndivior Inc.6189fb21-9432-45f8-8481-0bfaf3ccde952026-07-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1996193

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
6189fb21-9432-45f8-8481-0bfaf3ccde951.5 ML buprenorphine 200 MG/ML Prefilled Syringe [Sublocade]SBD42These highlights do not include all the information needed to use SUBLOCADE ® safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 200220251222
6189fb21-9432-45f8-8481-0bfaf3ccde951.5 ML Sublocade 200 MG/ML Prefilled SyringeSY42These highlights do not include all the information needed to use SUBLOCADE ® safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 200220251222
6189fb21-9432-45f8-8481-0bfaf3ccde95Sublocade 300 MG per 1.5 ML Prefilled SyringeSY42These highlights do not include all the information needed to use SUBLOCADE ® safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 200220251222
6189fb21-9432-45f8-8481-0bfaf3ccde95SUBLOCADE 300 MG in 1.5 mL Prefilled SyringePSN42These highlights do not include all the information needed to use SUBLOCADE ® safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 200220251222